Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

White Papers and Resources

Please find below the latest White Papers provided by agencies and companies within the healthcare and pharmaceutical industry. These are provided by external comoanies and are not approved of, checked or edited by PMLiVE or PMGroup Worldwide Ltd.

How does the government plan to reshape the NHS?

April 14, 2021 |  White Papers and Resources  |

Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care

Read More

Brought to you by  Wilmington Healthcare 

Integrated NHS finances: what do they mean for High Cost Drugs?

March 24, 2021 |  White Papers and Resources  |

Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs

Read More

Brought to you by  Wilmington Healthcare 

Covid-19: how is it affecting prescribing patterns?

February 11, 2021 |  White Papers and Resources  |

Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas

Read More

Brought to you by  Wilmington Healthcare 

Harness the power of data to map new patient pathways

November 24, 2020 |  White Papers and Resources  |

Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset

Read More

Brought to you by  Wilmington Healthcare 

How can pharma align its brand strategy with the NHS Reset?

November 9, 2020 |  White Papers and Resources  |

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Read More

Brought to you by  Wilmington Healthcare 

Covid-19 redefines rules of customer engagement

September 30, 2020 |  White Papers and Resources  |

Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs

Read More

Brought to you by  Wilmington Healthcare 

Covid-19 drives change in long-term conditions management

July 31, 2020 |  White Papers and Resources  |

Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are being empowered to manage their conditions at home

Read More

Brought to you by  Wilmington Healthcare 

Covid-19: how is it impacting on the NHS Long-term Plan?

June 16, 2020 |  White Papers and Resources  |

Oli Hudson and Paul Midgley, of Wilmington Healthcare, explain how coronavirus has expedited some parts of the plan but put others in jeopardy

Read More

Brought to you by  Wilmington Healthcare 

Covid-19: what could it mean for the diabetic population?

May 19, 2020 |  White Papers and Resources  |

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it

Read More

Brought to you by  Wilmington Healthcare 

Delivering true value: what does it mean for KAM in cancer care?

April 1, 2020 |  White Papers and Resources  |

Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must …

Read More

Brought to you by  Wilmington Healthcare 

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links